0.134 |
Cardiovascular Diseases |
Progress continues to be made in the understanding of Lp(a) metabolism, and Lp(a... |
BeFree,CTD_human,GAD,LHGDN |
24977982 |
Detail |
0.003 |
Carotid Artery Diseases |
NA |
BeFree,GAD |
|
Detail |
0.003 |
carotid stenosis |
NA |
LHGDN |
|
Detail |
0.003 |
intracranial aneurysm |
NA |
BeFree,GAD |
|
Detail |
0.002 |
brain ischemia |
NA |
GAD |
|
Detail |
0.002 |
chorioamnionitis |
NA |
GAD |
|
Detail |
<0.001 |
Colonic Neoplasms |
NA |
BeFree |
|
Detail |
<0.001 |
colorectal carcinoma |
NA |
BeFree |
|
Detail |
0.272 |
Coronary heart disease |
NA |
BeFree,CTD_human,GAD,GWASCAT,LHGDN |
|
Detail |
<0.001 |
Dementia, Vascular |
NA |
BeFree |
|
Detail |
<0.001 |
Diabetes Mellitus, Insulin-Dependent |
NA |
BeFree |
|
Detail |
0.003 |
Diabetes Mellitus, Non-Insulin-Dependent |
NA |
BeFree,GAD |
|
Detail |
0.003 |
Diabetic Nephropathy |
NA |
LHGDN |
|
Detail |
<0.001 |
diabetic retinopathy |
NA |
BeFree |
|
Detail |
<0.001 |
Experimental Autoimmune Encephalomyelitis |
NA |
BeFree |
|
Detail |
0.002 |
Fetal Membranes, Premature Rupture |
NA |
GAD |
|
Detail |
<0.001 |
HIV Infections |
NA |
BeFree |
|
Detail |
0.121 |
Hypercholesterolemia |
NA |
BeFree,CTD_human |
|
Detail |
0.001 |
Hypercholesterolemia, Familial |
NA |
BeFree |
|
Detail |
<0.001 |
Hyperlipoproteinemias |
NA |
BeFree |
|
Detail |
0.002 |
Hypersensitivity |
NA |
GAD |
|
Detail |
0.003 |
Hypertensive disease |
NA |
BeFree,LHGDN |
|
Detail |
0.120 |
Hypolipoproteinemias |
NA |
CTD_human |
|
Detail |
<0.001 |
Kidney Diseases |
NA |
BeFree |
|
Detail |
0.001 |
Kidney Failure, Chronic |
NA |
BeFree |
|
Detail |
0.002 |
Premature Obstetric Labor |
NA |
GAD |
|
Detail |
<0.001 |
chronic lymphocytic leukemia |
NA |
BeFree |
|
Detail |
<0.001 |
Acute Erythroblastic Leukemia |
Opposing regulation of megakaryopoiesis by LPA receptors 2 and 3 in K562 human e... |
BeFree |
25463482 |
Detail |
<0.001 |
acute promyelocytic leukemia |
NA |
BeFree |
|
Detail |
0.001 |
Liver neoplasms |
NA |
BeFree |
|
Detail |
<0.001 |
Malignant neoplasm of stomach |
NA |
BeFree |
|
Detail |
<0.001 |
multiple sclerosis |
NA |
BeFree |
|
Detail |
0.021 |
myocardial infarction |
NA |
BeFree,GAD |
|
Detail |
<0.001 |
Neoplasm Metastasis |
NA |
BeFree |
|
Detail |
<0.001 |
nephrotic syndrome |
NA |
BeFree |
|
Detail |
0.003 |
obesity |
NA |
BeFree,GAD |
|
Detail |
<0.001 |
osteosarcoma |
NA |
BeFree |
|
Detail |
0.002 |
ovarian carcinoma |
NA |
BeFree |
|
Detail |
<0.001 |
pneumonia |
NA |
BeFree |
|
Detail |
0.002 |
pre-eclampsia |
NA |
GAD |
|
Detail |
<0.001 |
pulmonary embolism |
NA |
BeFree |
|
Detail |
<0.001 |
kidney failure |
NA |
BeFree |
|
Detail |
<0.001 |
Retinal Diseases |
NA |
BeFree |
|
Detail |
<0.001 |
retinopathy of prematurity |
NA |
BeFree |
|
Detail |
0.136 |
Cerebrovascular accident |
NA |
BeFree,CTD_human,GAD,LHGDN |
|
Detail |
0.120 |
Thromboembolism |
NA |
BeFree,CTD_human |
|
Detail |
0.003 |
thrombosis |
NA |
LHGDN |
|
Detail |
0.002 |
Tobacco use disorder |
NA |
GAD |
|
Detail |
0.001 |
Vascular Diseases |
NA |
BeFree |
|
Detail |
0.120 |
Venous Thrombosis |
NA |
CTD_human |
|
Detail |
<0.001 |
Zellweger syndrome |
NA |
BeFree |
|
Detail |
<0.001 |
AIDS-Associated Nephropathy |
These findings suggest that LPA could be contributing to HIV-induced tubular cel... |
BeFree |
26079546 |
Detail |
0.009 |
Peripheral Vascular Diseases |
NA |
BeFree,GAD,LHGDN |
|
Detail |
<0.001 |
Polycystic Kidney, Autosomal Dominant |
Interestingly, LPA and its receptors have also been implicated in the tubular in... |
BeFree |
26079546 |
Detail |
<0.001 |
essential hypertension |
NA |
BeFree |
|
Detail |
0.002 |
Premature Birth |
NA |
GAD |
|
Detail |
<0.001 |
gastrointestinal carcinoma |
NA |
BeFree |
|
Detail |
<0.001 |
renal fibrosis |
LPA receptor type 1 (LPA₁) signaling influences the pathophysiology of many dise... |
BeFree |
24828490 |
Detail |
0.003 |
Myocardial Ischemia |
NA |
BeFree,GAD |
|
Detail |
<0.001 |
acute myocardial infarction |
NA |
BeFree |
|
Detail |
<0.001 |
retinal ischemia |
NA |
BeFree |
|
Detail |
<0.001 |
Aortic Aneurysm, Abdominal |
NA |
BeFree |
|
Detail |
<0.001 |
Tumor Progression |
Autotaxin (ENPP2/ATX) and lysophosphatidic acid (LPA) receptors represent two ke... |
BeFree |
25158955 |
Detail |
<0.001 |
Malignant ascites |
NA |
BeFree |
|
Detail |
0.003 |
Dyslipidemias |
NA |
BeFree,GAD |
|
Detail |
0.003 |
Restenosis |
NA |
BeFree,GAD |
|
Detail |
<0.001 |
Polygenic hypercholesterolemia |
NA |
BeFree |
|
Detail |
<0.001 |
Cholesteryl Ester Transfer Protein Deficiency |
NA |
BeFree |
|
Detail |
<0.001 |
Multiple malignancy |
NA |
BeFree |
|
Detail |
<0.001 |
Malignant neoplasm of prostate |
NA |
BeFree |
|
Detail |
0.120 |
Aortic valve calcification |
NA |
GWASCAT |
|
Detail |
<0.001 |
Alzheimer Disease, Late Onset |
NA |
BeFree |
|
Detail |
0.002 |
Metabolic syndrome X |
NA |
GAD |
|
Detail |
<0.001 |
Carotid Atherosclerosis |
NA |
BeFree |
|
Detail |
<0.001 |
Osteosarcoma of bone |
NA |
BeFree |
|
Detail |
<0.001 |
Carcinogenesis |
NA |
BeFree |
|
Detail |
<0.001 |
prostate carcinoma |
NA |
BeFree |
|
Detail |
<0.001 |
Epithelial ovarian cancer |
NA |
BeFree |
|
Detail |
0.002 |
breast carcinoma |
NA |
BeFree |
|
Detail |
<0.001 |
Malignant neoplasm of gastrointestinal tract |
NA |
BeFree |
|
Detail |
0.002 |
colon carcinoma |
NA |
BeFree |
|
Detail |
<0.001 |
stomach carcinoma |
NA |
BeFree |
|
Detail |
<0.001 |
Carcinoma of bladder |
NA |
BeFree |
|
Detail |
<0.001 |
Acute Cerebrovascular Accidents |
NA |
BeFree |
|
Detail |
0.003 |
arteriolosclerosis |
NA |
LHGDN |
|
Detail |
<0.001 |
ovarian neoplasm |
NA |
BeFree |
|
Detail |
<0.001 |
Ischemic stroke |
NA |
BeFree |
|
Detail |
<0.001 |
Acute coronary syndrome |
NA |
BeFree |
|
Detail |
0.002 |
Malignant neoplasm of ovary |
NA |
BeFree |
|
Detail |
<0.001 |
Mammary Tumorigenesis |
NA |
BeFree |
|
Detail |
<0.001 |
Xenograft Model |
NA |
BeFree |
|
Detail |
<0.001 |
colorectal cancer |
NA |
BeFree |
|
Detail |
<0.001 |
Non-Malignant Ascites Adverse Event |
NA |
BeFree |
|
Detail |
<0.001 |
Peripheral Arterial Diseases |
NA |
BeFree |
|
Detail |
<0.001 |
Idiopathic Pulmonary Fibrosis |
NA |
BeFree |
|
Detail |
0.002 |
Venous thromboembolism |
NA |
GAD |
|
Detail |
0.150 |
coronary artery disease |
NA |
BeFree,CTD_human,GAD,LHGDN |
|
Detail |
0.002 |
liver carcinoma |
NA |
BeFree |
|
Detail |
<0.001 |
Chronic kidney disease stage 5 |
NA |
BeFree |
|
Detail |
<0.001 |
Thrombophilia, hereditary |
NA |
BeFree |
|
Detail |
0.002 |
Infection of amniotic sac and membranes, unspecified, unspecified trimester, not applicable or unspecified |
NA |
GAD |
|
Detail |
<0.001 |
Ischemic Cerebrovascular Accident |
NA |
BeFree |
|
Detail |
0.003 |
Alzheimer's disease |
NA |
BeFree,GAD |
|
Detail |
<0.001 |
amyloidosis |
NA |
BeFree |
|
Detail |
0.002 |
amyotrophic lateral sclerosis |
NA |
GAD |
|
Detail |
<0.001 |
Cooley's anemia |
NA |
BeFree |
|
Detail |
0.010 |
arteriosclerosis |
NA |
BeFree,LHGDN |
|
Detail |
<0.001 |
rheumatoid arthritis |
NA |
BeFree |
|
Detail |
0.002 |
asthma |
NA |
GAD |
|
Detail |
0.133 |
atherosclerosis |
NA |
BeFree,CTD_human,GAD,LHGDN |
|
Detail |
<0.001 |
Malignant neoplasm of urinary bladder |
NA |
BeFree |
|
Detail |
<0.001 |
Blood Coagulation Disorders |
NA |
BeFree |
|
Detail |
0.002 |
Malignant neoplasm of breast |
NA |
BeFree |
|
Detail |
<0.001 |
Calcific stenosis |
It is possible to conclude that apoB (XbaI, rs1042031, and rs6725189), ACE (rs43... |
BeFree |
24903972 |
Detail |
0.002 |
Malignant tumor of colon |
NA |
BeFree |
|
Detail |